ResMed Shifts Board Leadership as Longtime Director Retires
Event summary
- Carol Burt, current Nominating and Governance Chair, to become Lead Director on November 15, 2026.
- Ron Taylor, Lead Director since 2013, retiring after 21 years on ResMed’s Board.
- Taylor not standing for reelection at the 2026 Annual Meeting of Stockholders on November 18, 2026.
- Burt has served on ResMed’s Board since 2013 and chairs the Nominating and Governance Committee.
The big picture
ResMed’s board leadership transition comes at a time when the health technology sector is undergoing significant digital transformation. Burt’s extensive governance experience and healthcare industry knowledge position her to guide the company through evolving market dynamics and regulatory landscapes. The shift also marks the end of an era for Taylor, who has been instrumental in ResMed’s growth and transformation over the past two decades.
What we're watching
- Governance Dynamics
- How Carol Burt’s leadership style will differ from Ron Taylor’s and impact board oversight.
- Strategic Continuity
- Whether Burt can sustain ResMed’s long-term growth strategy amid industry shifts.
- Board Experience
- The pace at which Burt integrates her healthcare industry knowledge into ResMed’s governance.
Related topics